Cellular Dynamics International, Inc.

Madison, WI 53711

Market Performance

NASDAQ: ICEL
52 Week High $5
52 Week Low $17

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $500K
First Award Date 09/01/07
Most Recent Award Date 08/01/08

Key Personnel

Last Name Name Awards Contact
He Jia-Qiang He 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-24
Budget: 08/01/08 - 07/31/10

DESCRIPTION (provided by applicant): Drug-induced QT prolongation is a common cardiac disorder associated with an increased risk for the ventricular arrhythmia torsades de pointes and sudden death. Recognition of this condition has led to increased focus on cardiac toxicity in drug development. The FDA now requires cardiac safety studies prior t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-24
Budget: 09/01/07 - 07/31/08

DESCRIPTION (provided by applicant): Drug-induced QT prolongation is a common cardiac disorder associated with an increased risk for the ventricular arrhythmia torsades de pointes and sudden death. Recognition of this condition has led to increased focus on cardiac toxicity in drug development. The FDA now requires cardiac safety studies prior t...